Performance analysis of Theravance Biopharma (TBPH)
Annual Return
Over the past 3 years, TBPH has had an average annual return of +12.82%, underperforming the benchmark SPY, which returned +22.45% annual.
Over the past 5 years, TBPH has had an average annual return of -0.80%, underperforming the benchmark SPY, which returned +13.88% annual.
Over the past 10 years, TBPH has had an average annual return of -3.73%, underperforming the benchmark SPY, which returned +15.44% annual.
Since May 16, 2014, TBPH has had an average annual return of -2.99%, underperforming the benchmark SPY, which returned +14.13% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -14.91% | +98.85% | -16.28% | +0.16% | +1.54% | -37.82% | -31.36% | +1.18% | -8.25% | -12.52% | +94.50% | +9.86% |
| 2014 | |||||||||||
| -35.02% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +1.23% | -3.64% | -11.07% | +3.14% | -4.06% | -0.87% | -14.91% | ||||||
| 2025 | -0.32% | -0.32% | -4.49% | +9.41% | -6.23% | +20.40% | +1.19% | +24.36% | +5.19% | +0.41% | +38.47% | -7.83% | +98.85% |
| 2024 | -15.65% | -0.10% | -5.28% | -5.91% | +2.12% | -1.62% | +19.23% | -18.40% | -2.31% | +2.25% | +12.26% | +1.71% | -16.28% |
| 2023 | -3.66% | -0.08% | +0.47% | -0.19% | +3.22% | -7.41% | -4.46% | -3.74% | -9.33% | +9.36% | +11.02% | +7.25% | +0.16% |
| 2022 | -17.56% | +10.53% | -5.06% | +0.94% | -9.02% | +3.19% | -2.99% | +2.51% | +12.54% | -1.68% | +7.92% | +4.29% | +1.54% |
| 2021 | +4.88% | -11.10% | +23.17% | -3.27% | -12.47% | -15.97% | -10.61% | -36.05% | -10.84% | +5% | +8.13% | +31.54% | -37.82% |
| 2020 | +7.69% | -12.67% | -5.09% | +26.18% | -13.41% | -16.87% | -7.48% | -5.62% | -19.34% | +27.91% | -12.26% | +7.11% | -31.36% |
| 2019 | +1.80% | -6.83% | -6.59% | +5.21% | -30.31% | -1.75% | +27.69% | +5.66% | -11.58% | -17.24% | +34.98% | +18.98% | +1.18% |
| 2018 | -5.19% | -0.30% | -8.00% | -0.75% | +1.13% | -6.82% | +5.60% | +20.97% | +12.77% | -25.71% | +13.75% | -7.32% | -8.25% |
| 2017 | -6.02% | +2.20% | +20.25% | +9.53% | -9.50% | +9.15% | -19.35% | +1.68% | +4.81% | -15.71% | -1.42% | -1.97% | -12.52% |
Drawdown analysis of Theravance Biopharma (TBPH)
The maximum drawdown for the TBPH was -84.09%, occurring on Sep 15, 2021. This drawdown has not yet recovered.
The current TBPH drawdown is -62.59%.
Since May 16, 2014 TBPH has experienced the following drawdowns:
- 50% or more: 2 times
- 40% or more: 2 times
- 30% or more: 3 times
- 20% or more: 3 times
- 10% or more: 5 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -84.09% | Jun 22, 2017 | 1065 | Sep 15, 2021 | Ongoing | Ongoing | Ongoing |
| -68.80% | Jun 23, 2014 | 320 | Sep 29, 2015 | 246 | Sep 20, 2016 | 566 |
| -36.31% | Oct 10, 2016 | 18 | Nov 3, 2016 | 113 | Apr 19, 2017 | 131 |
| -15.07% | May 16, 2014 | 10 | Jun 2, 2014 | 1 | Jun 3, 2014 | 11 |
| -12.76% | May 1, 2017 | 15 | May 22, 2017 | 22 | Jun 22, 2017 | 37 |
| -6.80% | Jun 16, 2014 | 2 | Jun 18, 2014 | 2 | Jun 20, 2014 | 4 |
| -4.84% | Sep 27, 2016 | 2 | Sep 29, 2016 | 4 | Oct 5, 2016 | 6 |
| -2.75% | Oct 5, 2016 | 1 | Oct 6, 2016 | 2 | Oct 10, 2016 | 3 |
| -2.18% | Sep 22, 2016 | 2 | Sep 26, 2016 | 1 | Sep 27, 2016 | 3 |
| -1.03% | Apr 26, 2017 | 2 | Apr 28, 2017 | 1 | May 1, 2017 | 3 |
| -0.94% | Apr 20, 2017 | 1 | Apr 21, 2017 | 1 | Apr 24, 2017 | 2 |